AdrenalectomyNCT06697652
Readmission After Adrenalectomy
An observational study of Adrenalectomy, run by Zagazig University.
Trial summary
to evaluate early hospital enterance after pheo surg. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Adrenalectomy
- What is being tested?
- adrenalectomy
- Type of treatment
- Surgery or procedure
- How many people
- 346 participants
- Where
- No sites listed yet
- Study dates
- 1 Sep 2016to 1 Sep 2024
- How long will I take part?
- 30 Days
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patients with pheo
Who may be able to join
- patients with pheo
Who cannot join
- non reactive
- missed data
About this study
Official title: Early Readmission After Adrenalectomy for PHEO.
to evaluate early hospital enterance after pheo surg.
- Conditions
- Adrenalectomy
- Being tested
- adrenalectomy
- Keywords
- adrenalectomy, hospital, risk factors
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
adrenalectomyProcedure or surgery
adrenalectomy
| Study group | Role | What they receive |
|---|---|---|
| hospital readmission | hospital readmission for complications Receives: Procedure: adrenalectomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
readmission rate
number of hospital readmission
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Nov 2024
- Study start1 Sep 2016
- Primary completion1 Sep 2024
- Study completion1 Sep 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AdrenalectomyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 346 participants (actual)
- Target duration
- 30 Days
Sponsor and investigators
- Lead sponsor
- Zagazig University
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Tamer.A.A.M.Habeeb, Zagazig University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06697652
- Sponsor's protocol ID
- early readmission after pheo s
- Status last verified
- Nov 2024
- First submitted
- 18 Nov 2024
- Last updated
- 20 Nov 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 20 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Early Readmission After Adrenalectomy for PHEO.
- ClinicalTrials.gov ID
- NCT06697652
- Acronym / sponsor ID
- early readmission after pheo s
- Conditions
- Adrenalectomy
- Keywords
- adrenalectomy, hospital, risk factors
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 346 participants (actual)
- Lead sponsor
- Zagazig UniversityOther government
- Study start
- 1 Sep 2016 (actual)
- Primary completion
- 1 Sep 2024 (actual)
- Study completion
- 1 Sep 2024 (actual)
- First posted
- 20 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
to evaluate early hospital enterance after pheo surg.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 30 Days
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| hospital readmission | – | Procedure: adrenalectomyhospital readmission for complications |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patients with pheo
Key inclusion criteria (1 listed)
- patients with pheo
Key exclusion criteria (2 listed)
- non reactive
- missed data
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| adrenalectomyadrenalectomy | Procedure or surgery | hospital readmission |
Primary outcome
readmission rate
Time frame: 30 days
number of hospital readmission
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Nov 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Adrenalectomy
Recruiting
Robotic Adrenalectomy With Versus Without Indocyanine Green Fluorescence Imaging
Adrenalectomy
RecruitingPhase 2
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
Mild Autonomous Cortisol Secretion (MACS), Adrenalectomy; Status
Recruiting
Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension
Primary Aldosteronism Due to Conn Adenoma, Radiofrequency Ablation Treatment
Recruiting
Laparoscopic Versus Robotic Lateral Transabdominal Adrenalectomy
Adrenalectomy
RecruitingObservational study
CHina Adrenal Venous saMPling InvestigatiON
Hyperaldosteronism, Adrenal Venous Sampling
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Adrenalectomy, run by Zagazig University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
readmission rate (time frame: 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2024; AzTrials last refreshed its copy on 29 Oct 2026.